日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity.

PTPN22-CD45 双磷酸酶逆向反馈增强 TCR 信号传导和自身免疫

Yang Shen, Santelli Eugenio, Gonzalez Carlos G, Johnson Wade T, Choi Irene V, Zhuang Chuling, Ro Myungja, Rossitto Leigh-Ana M, Yu I-Shing, Lin Shu-Wha, Zhan Yuan, Chen Qinwei, Yoshihara Jonathan D, Wallace Daniel J, Jefferies Caroline A, Yamashita Michifumi, Gonzalez David J, Ainsworth Richard I, Shah Nisarg J, Stanford Stephanie M, Bottini Nunzio

Targeting tGLI1, a novel mediator of tumor therapeutic resistance, using Ketoconazole sensitizes glioblastoma to CDK4/6 therapy and chemoradiation.

使用酮康唑靶向肿瘤治疗耐药性的新介质 tGLI1,可使胶质母细胞瘤对 CDK4/6 疗法和放化疗敏感

Yu Yang, Arrigo Austin, Chandra Ankush, Zhuang Chuling, Najjar Mariana K, Khan Munazza S, Zhu Dongqin, Dono Antonio, Strowd Roy E, Tandon Nitin, Zhu Jay-Jiguang, Hsu Sigmund H, Esquenazi Yoshua, Chan Michael, Lo Hui-Wen

Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers

使用恩曲替尼和帕克替尼双重抑制TrkA和JAK2通路可抑制HER2阳性和三阴性乳腺癌的生长和转移。

Regua, Angelina T; Bindal, Shivani; Najjar, Mariana K; Zhuang, Chuling; Khan, Munazza; Arrigo, Austin B J; Gonzalez, Anneliese O; Zhang, Xinhai R; Zhu, Jay-Jiguang; Watabe, Kounosuke; Lo, Hui-Wen

Interleukin-1 Receptor-Associated Kinase 1 in Cancer Metastasis and Therapeutic Resistance: Mechanistic Insights and Translational Advances

白细胞介素-1受体相关激酶1在癌症转移和治疗耐药中的作用:机制见解和转化进展

Najjar, Mariana K; Khan, Munazza S; Zhuang, Chuling; Chandra, Ankush; Lo, Hui-Wen

Crosstalk between breast cancer-derived microRNAs and brain microenvironmental cells in breast cancer brain metastasis

乳腺癌脑转移中乳腺癌来源的microRNA与脑微环境细胞之间的相互作用

Khan, Munazza S; Wong, Grace L; Zhuang, Chuling; Najjar, Mariana K; Lo, Hui-Wen